4//SEC Filing
Grygiel Nancy A. 4
Accession 0000318154-25-000062
CIK 0000318154other
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 7:21 PM ET
Size
5.7 KB
Accession
0000318154-25-000062
Insider Transaction Report
Form 4
AMGEN INCAMGN
Grygiel Nancy A.
SVP & CCO
Transactions
- Sale
Common Stock
2025-08-20$296.99/sh−1,267$376,280→ 7,209 total
Holdings
- 103.808(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]These shares include 80 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- [F2]These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeother
Related Parties
1- filerCIK 0001816414
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 7:21 PM ET
- Size
- 5.7 KB